海外の治験の状況「1」での検索結果
11240件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Role of Pregnancy Related Hormones in Lowering the Insulin Requirement in Pregnant Women With Type 1 Diabetes
- Type 1 Diabetes;Type 1 Diabetes;Type 1 Diabetes
- United States
- 2010-12-20
Not recruiting
- Clinical and Immunological Evaluation of Children With Allergies
- Hypersensitivity, Immediate;Hypersensitivity, Immediate;Hypersensitivity, Immediate;Hypersensitivity, Immediate
- United States
- 2005-01-29
Not recruiting
- Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy
- Type 1 Diabetes;Type 1 Diabetes;Type 1 Diabetes
- Canada, United States
- 2007-01-02
Not recruiting
- Incentives, Cognitive Training and Internet Therapy for Teens With Poorly Controlled Type 1 Diabetes
- Type 1 Diabetes;Type 1 Diabetes;Type 1 Diabetes
- United States
- 2012-10-19
Not recruiting
- Four Way Crossover Closed Loop With Exercise Detection
- Type 1 Diabetes;Type 1 Diabetes;Type 1 Diabetes
- United States
- 2016-07-28
Not recruiting
- Omental Islet Transplant
- Type 1 Diabetes;Type 1 Diabetes;Type 1 Diabetes
- Canada
- 2016-06-20
Not recruiting
- A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK001
- Atopy;Atopy
- United States
- 2015-09-15
Not recruiting
- Can Short Latency Afferent Inhibition Give us Clues to Better DYT 1 Dystonia Treatments?
- DYT-1;DYT1;DYT 1;Dystonia
- United States
- 2011-09-14
Not recruiting
- Aralast alpha1-proteinase Inhibitor Surveillance Study
- Alpha 1-Antitrypsin (AAT) Deficiency;Alpha 1-Antitrypsin (AAT) Deficiency;Alpha 1-Antitrypsin (AAT) Deficiency;Alpha 1-Antitrypsin (AAT) Deficiency
- United States
- 2006-04-10
Recruiting
- Linkage and Identification of (a) Candidate Gene(s) for Tooth Disorders
- Anodontia
- United States
- 2001-11-06
Not recruiting
- The Insulin-Only Bionic Pancreas Pivotal Trial
- Diabetes Mellitus;Type 1 Diabetes;Diabetes Mellitus, Type 1
- United States
- 2019-12-13
Recruiting
- MEK 1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
- Neurofibromatosis 1;Plexiform Neurofibromas
- United States
- 2015-12-31
Not Recruiting
- An open, 3-cohort, phase II trial testing oral administration of lucitanib in patients with FGFR1-amplified or non-amplified estrogen receptor positive metastatic breast cancer.
- FGFR1-amplified or non-amplified estrogen receptor positive metastatic breast cancer MedDRA version: 16.1 Level: PT Classification code 10055113 Term: Breast cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 16.1 Level: LLT Classification code 10070575 Term: Estrogen receptor positive breast cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Canada, France, Germany, Hungary, Italy, Spain, United Kingdom
- 2013-06-12
Authorised
- An open, 3-cohort, phase II trial testing oral administration of lucitanib in patients with FGFR1-amplified or non-amplified estrogen receptor positive metastatic breast cancer.
- FGFR1-amplified or non-amplified estrogen receptor positive metastatic breast cancer MedDRA version: 18.1 Level: PT Classification code 10055113 Term: Breast cancer metastatic System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 18.1 Level: LLT Classification code 10070575 Term: Estrogen receptor positive breast cancer System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, Canada, France, Germany, Hungary, Italy, Spain, United Kingdom
- 2013-06-12
Not Recruiting
- Clinical research study to assess the safety and effectiveness of alpha1-proteinase inhibitor (A1-PI) administered by intravenous application to patients with alpha1-proteinase deficiency and emphysema who have completed the 2-year treatment and observation period in the Phase III/IV Zemaira® CE1226_4001.
- Chronic augmentation and maintenance therapy in individuals with alpha1-proteinase inhibitor (A1-PI) deficiency and clinical evidence of emphysema. MedDRA version: 17.0 Level: LLT Classification code 10001811 Term: Alpha-1 proteinase inhibitor deficiency System Organ Class: 100000004850 ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- Australia, Canada, Czech Republic, Denmark, Estonia, Finland, Germany, Ireland, Poland, Romania, Sweden
- 2008-01-11
Not recruiting
- An Open Label, Multi-Center, Randomized, Parallel Group Study Comparing the Efficacy and Safety of Insulin VIAject™ and Regular Human Insulin in Patients With Type 1 Diabetes Mellitus
- Type 1 Diabetes Mellitus
- United States
- 2007-10-05
Recruiting
- The Safety and Efficacy of Alpha-1 Antitrypsin (AAT) for the Prevention of Graft-Versus-host Disease (GVHD) in Patients Receiving Hematopoietic Cell Transplant
- Graft Versus Host Disease
- United States
- 2019-01-14
Recruiting
- Intravenous Gene Transfer With an AAV9 Vector Expressing Human <=-Galactosidase in Type II GM1 Gangliosidosis
- Lysosomal Diseases;Gangliosidosis;GM1
- United States
- 2019-05-15
Not Recruiting
- Evaluation of the Safety and Efficacy of Treatment With BOTOX® (Botulinum Toxin Type A) Purified Neurotoxin Complex for Subjects With Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines)
- Facial Rhytides (Forehead Lines, Glabellar Lines, Lateral Canthal Lines) br>MedDRA version: 18.0 Level: LLT Classification code 10048043 Term: Wrinkling System Organ Class: 100000004858 ;Therapeutic area: Not possible to specify
- Belgium, Canada, Germany, United Kingdom, United States
- 2014-09-24
Not recruiting
- Phase I Study of Romidepsin, Gemcitabine, Oxaliplatin, and Dexamethasone in Patients With Relapsed/Refractory Aggressive Lymphomas
- Lymphoma, T-Cell, Cutaneous;Lymphoma, T-Cell, Peripheral;Hodgkin Disease;Lymphoma, Large B-Cell, Diffuse
- United States
- 2014-07-01